Health Archive » July, 2006

Health - July, 2006

143 articles

• FTC Probes Mylan Over Provigil Settlements
• Digene Wins Arbitration Ruling Over HPV License
• Smith & Nephew Blames Sales Rep In Antitrust Probe
• Boston Scientific, St. Jude Settle Four Patent Suits
• State Attorneys General Reject Revised Plavix Deal
• FDA Breast Implant Decisions Cleared By Senate Panel
• In Reversal, FDA Opens Door To Morning-After Pill
• ImClone Motion Denied In Erbitux Case
• Pfizer Puts General Counsel In Charge
• House Passes Medical Data Technology Bill
• Shareholders Take Aim At HCA Buyout Deal
• FBI Raids Bristol-Myers Over Plavix Deal
• Trial Begins In Latest Wyeth Diet Drug Case
• Intermune Eyes Settlement Over Off-Label Marketing
• Biomet Says DoJ Scales Down Antitrust Probe
• SEC Settles Case Over Insider Trading On FDA Decision
• DOJ Launches Criminal Probe Into Plavix Deal
• Bill Would Move Vaccine Safety Out Of CDC
• J&J Unit Takes On Wyeth's Effexor In Patent Suit
• Zimmer Tries To Clear Name In Price-Fixing Scandal
• Abbott Wins Antitrust Challenge Over HIV Drug Cocktail
• Tyco Sticks Applied Medical With Fresh Patent Suit
• Invitrogen Gets Biotech Patent Win In Jury Trial
• HealthSouth Gets New General Counsel
• Judge Tosses Patent Case Against Stryker
• Korea Pushes Drug-Pricing Law
• Universities, Hospitals Join Patent Litigation Bonanza
• Lawsuits, Investigations Unaffected By HCA Sale
• States Wade Into Stem-Cell Research Controversy
• Upsher-Smith, Unigene Sue Apotex After ANDA Filing
• SEC Investigates Par Pharmaceutical
• Eye Care Company Says It's Not Eyeing Rival's Patent
• St. Vincent Sells Off Hospital In $15M Deal
• Jury Awards $5M In Infant Tylenol Poisoning Case
• Orthopedic Industry Braces For Possible Storm
• Judge Holds Off On Hospital Settlement Approval
• Another Exec Fined In HealthSouth Scandal
• FDA Bolsters Rules On Outside Advisors
• Shareholders Committee Will Stay In OCA Bankruptcy
• Plavix Ruling From Attorneys General Imminent
• America's Top Health Litigators: Drinker Biddle & Reath
• Union Ordered To Pay Fine For Defamation
• N.J. High Court Mulls Vioxx Class Status; $30B At Stake
• Swiss University Sues Synthes In Pilot Case
• RxUSA Files New Suit Against Wholeseller
• Early Approval For Astra's Asthma Drug Stuns Analysts
• Roche Rallies In Wake Of Enzo Biochem Ruling
• Erbitux Trial Awaits Judge's Decision
• America's Top Health Litigators: Reed Smith
• Political Pressure-Cooker Mentality At FDA: Report
• Orthopedic Company Antitrust Subpoena "Narrowed"
• Par Pharmaceutical Hit With Securities Suits
• Amgen Criticizes Roche's Anemia Study
• Judge: No Infringement In Assays Patent Case
• Senators Take Aim At Authorized Generics
• Suit Alleges Conspiracy Among Drug Cos., Wholesalers
• Elan Files Patent Suit Over Breast Cancer Drug
• FTC Commissioner Slams Authorized Generics
• Hospital To Pay $3.75M Over Kickback Scheme
• Endocare Settles Fraud Case With SEC, DOJ
• Judge OKs St. Vincent's $21.2M Hospital Sell-Off
• ImClone, Merck Reach Deal Over Erbitux
• America's Top Health Litigators: McDermott Will & Emery
• Bush Vetoes Stem-Cell Funding On "Moral" Grounds
• Group Looks To Overturn Stem Cell Patents
• "Wal-Mart Law" Struck Down In Federal Court
• E-mails Question FDA Review Process For Ketek
• Court Issues Markman Ruling In Enzo Biochem Case
• Hospital Settlement Attracts Scrutiny
• Fed. Circuit Affirms University's Grip On Allergy Patent
• Fourth Circuit Rejects Another Authorized Generics Challenge
• America's Top Health Litigators: Sidley Austin
• Court Finds Non-Infringement In Alaris, ICU Case
• Encore Medical Shareholders Target $870M Merger
• FDA OKs Medtronic's New Glucose Monitor
• America's Top Health Litigators: Jones Day
• Court Upholds Blood Pressure Drug Patent
• Senate Clears Stem-Cell Funding As Veto Looms
• Settlement Gets To Heart Of Stent Lawsuit
• Beazley Scores U.S. Health Care Legal Veteran
• Bio-Rad Settles Lengthy Licensing Dispute
• U.S. Trustee Objects To World Health Asset Sale
• Jury Denies Baxter's $87M Bid In Dialysis Dispute
• Six Years After Wyeth Debacle, Birth Control Rod OK'd
• Medtronic To Pay $40M To Settle Kickback Charges
• Generic Drug Maker Gets Chapter 11 OK
• Eli Lilly Gets Green Light For New Use Of Gemzar
• Orthopedic Makers Conspired To Fix Prices, Suit Claims
• Pfizer Stuck With 17 New Lipitor Suits
• FDA Opts To Fast Track Constipation Drug
• Shadow Of Veto Clouds Senate Stem-Cell Vote
• Roche, Sanofi Settle Australian Vitamins Cartel Action
• America's Top Health Litigators: Fitzpatrick, Cella
• Class Action Adds To Drug Maker's Troubles
• America's Top Health Litigators: McCarter & English
• FDA Calls Off Closed Hearing On Blood Substitute
• Lawmakers Try To Put Brakes On Medicare Overhaul
• Five Suits Charge Blue Shield Abandoned Patients
• Rulings Highlight Community Patent Rift
• In Blow To Ivax, Judge Upholds Lexapro Patent
• Health Courts? No Thanks, Say Trial Lawyers
• Generic Drug Settlement Prompts More FTC Scrutiny
• Merck Wins New Jersey Vioxx Case
• New Study Supports Biotech Fears Over USPTO Changes
• FDA Draws Fire For Closed Hearing On Blood Substitute
• America's Top Health Litigators: Kaye Scholer
• FDA Backs Boston Scientific's Recall Of Heart Devices
• Hospice Co. Pays $13M To Settle False Claims Probes
• America's Top Health Litigators: Shook, Hardy & Bacon
• Judge Tosses Sandoz' Injunctive Bid Over Zocor
• Merck Strategy Still Murky As Jury Mulls Vioxx Claims
• Senate Votes To Allow Access To Canadian Drugs
• HealthSouth Bigwig Loses Appeal In Fraud Case
• SeraCare, Shareholders Agree To Exclusivity Deal
• Medegen Unit Hits ICU Medical With Suit
• Forest Sues To Keep Generic Lexapro Off Market
• Chemical Cos. Settle Spat Over Cystic Fibrosis Drug
• Vision Companies Settle Patent Dispute
• Future Looks Grim For Charitable Hospitals
• Dusa Targets Chemical Supplier, Physicians In Suits
• FTC Scrutiny Casts Doubt On Plavix Settlement
• FDA Slacking On Post-Approval Follow-Up: Report
• CalPERS Sues UnitedHealth Over Options Backdating
• Lawyer: Heart Attack Caused By Bad Health, Not Vioxx
• America's Top Health Litigators: Dechert
• Under Vioxx Fire, Merck Faces Fosamax Claims Too
• As Drug Risks Mount, Senators Put Pressure On FDA
• Lord Bissell's Health Care Practice Balloons
• Government Softens Blow Of Medicaid Identity Law
• 10 Stand-Out Firms Win Industry's Confidence
• Lawsuit Targets Director Of USPTO
• Amgen Loses Battle In Anemia War With La Roche
• University, Nektar Settle Patent Feud For $25M
• Shareholders Seek To End SeraCare's Ch. 11 Control
• Tenet Settles One Year After Katrina
• J&J Subsidiaries Fight Back Generic Challenge
• FTC Detects Cancer Screening Monopoly
• Defendants Cave To Acacia Over Resource Tools
• Ruling Sets Up Patent Battle Over Growth Treatment
• Device Makers Settle Suit Over Incontinence Treatment
• Hospitals Rail Against Medicaid Citizenship Law
• Doctor Testifies Merck Knew Of Vioxx Risk
• Citizen Petitions Come Under Fire In Pharma War